相似文献
1
Protein kinase C inhibitors for immune disorders.
Drug Discov Today. 2014 Aug;19(8):1217-21. doi: 10.1016/j.drudis.2014.05.008. Epub 2014 Jun 2.
2
PKC inhibitors: potential in T cell-dependent immune diseases.
Curr Opin Cell Biol. 2009 Apr;21(2):262-7. doi: 10.1016/j.ceb.2008.12.008. Epub 2009 Feb 3.
3
Protein kinase C isozymes as potential therapeutic targets in immune disorders.
Expert Opin Ther Targets. 2008 May;12(5):535-52. doi: 10.1517/14728222.12.5.535.
4
The arrival of JAK inhibitors: advancing the treatment of immune and hematologic disorders.
BioDrugs. 2013 Oct;27(5):431-8. doi: 10.1007/s40259-013-0040-7.
5
Targeting protein kinase C subtypes in pancreatic cancer.
Expert Rev Anticancer Ther. 2015 Apr;15(4):433-8. doi: 10.1586/14737140.2015.1003810. Epub 2015 Jan 20.
6
Protein kinase C inhibitors: a patent review (2008 - 2009).
Expert Opin Ther Pat. 2013 Oct;23(10):1297-315. doi: 10.1517/13543776.2013.805205. Epub 2013 Jun 25.
7
Preclinical and clinical development of novel agents that target the protein kinase C family.
Semin Oncol. 2006 Aug;33(4):466-78. doi: 10.1053/j.seminoncol.2006.04.009.
8
Specifying protein kinase C functions in melanoma.
Pigment Cell Melanoma Res. 2012 Jul;25(4):466-76. doi: 10.1111/j.1755-148X.2012.01015.x.
9
Classical PKC isoforms in cancer.
Pharmacol Res. 2007 Jun;55(6):477-86. doi: 10.1016/j.phrs.2007.04.001. Epub 2007 Apr 21.
10
The pros and cons of targeting protein kinase C (PKC) in the management of cancer patients.
Curr Pharm Biotechnol. 2011 Nov;12(11):1961-73. doi: 10.2174/138920111798376950.
引用本文的文献
1
Cysteine-rich zinc finger proteins and the nuclear factor kappa-B pathway.
Front Chem Biol. 2024;3. doi: 10.3389/fchbi.2024.1503390. Epub 2024 Dec 19.
2
Utilizing Nanopore direct RNA sequencing of blood from patients with sepsis for discovery of co- and post-transcriptional disease biomarkers.
BMC Infect Dis. 2025 May 13;25(1):692. doi: 10.1186/s12879-025-11078-z.
3
PKCδ Protects against Lupus Autoimmunity.
Biomedicines. 2024 Jun 19;12(6):1364. doi: 10.3390/biomedicines12061364.
4
An Update on Protein Kinases as Therapeutic Targets-Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular Diseases.
Int J Mol Sci. 2023 Dec 18;24(24):17600. doi: 10.3390/ijms242417600.
5
The Abundant Phytocannabinoids in Rheumatoid Arthritis: Therapeutic Targets and Molecular Processes Identified Using Integrated Bioinformatics and Network Pharmacology.
Life (Basel). 2023 Mar 5;13(3):700. doi: 10.3390/life13030700.
6
Pharmacological strategies for mitigating anti-TNF biologic immunogenicity in rheumatoid arthritis patients.
Curr Opin Pharmacol. 2023 Feb;68:102320. doi: 10.1016/j.coph.2022.102320. Epub 2022 Dec 27.
7
Targeting Protein Kinase C for Cancer Therapy.
Cancers (Basel). 2022 Feb 22;14(5):1104. doi: 10.3390/cancers14051104.
8
Aberrance of Zinc Metalloenzymes-Induced Human Diseases and Its Potential Mechanisms.
Nutrients. 2021 Dec 13;13(12):4456. doi: 10.3390/nu13124456.
9
Integrative pharmacological mechanism of vitamin C combined with glycyrrhizic acid against COVID-19: findings of bioinformatics analyses.
Brief Bioinform. 2021 Mar 22;22(2):1161-1174. doi: 10.1093/bib/bbaa141.
10
Bioinformatics analysis to screen for critical genes between survived and non‑survived patients with sepsis.
Mol Med Rep. 2018 Oct;18(4):3737-3743. doi: 10.3892/mmr.2018.9408. Epub 2018 Aug 21.
本文引用的文献
1
Pharmacologic inhibition of PKCα and PKCθ prevents GVHD while preserving GVL activity in mice.
Blood. 2013 Oct 3;122(14):2500-11. doi: 10.1182/blood-2012-12-471938. Epub 2013 Aug 1.
2
B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ.
Blood. 2013 Apr 18;121(16):3112-6. doi: 10.1182/blood-2012-10-460741. Epub 2013 Jan 14.
3
Seventy-five genetic loci influencing the human red blood cell.
Nature. 2012 Dec 20;492(7429):369-75. doi: 10.1038/nature11677. Epub 2012 Dec 5.
4
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.
Nature. 2012 Nov 1;491(7422):119-24. doi: 10.1038/nature11582.
5
Involvement of distinct PKC gene products in T cell functions.
Front Immunol. 2012 Aug 6;3:220. doi: 10.3389/fimmu.2012.00220. eCollection 2012.
6
Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population.
Nat Genet. 2012 Mar 25;44(5):511-6. doi: 10.1038/ng.2231.
7
PKCθ: a new target for selective immunosuppression.
Expert Rev Clin Immunol. 2012 Mar;8(3):205-8. doi: 10.1586/eci.12.8.
8
Sotrastaurin (AEB071) alone and in combination with cyclosporine A prolongs survival times of non-human primate recipients of life-supporting kidney allografts.
Transplantation. 2012 Jan 27;93(2):156-64. doi: 10.1097/TP.0b013e31823cf92f.
9
Protein kinase C η is required for T cell activation and homeostatic proliferation.
Sci Signal. 2011 Dec 6;4(202):ra84. doi: 10.1126/scisignal.2002058.
10
A motif in the V3 domain of the kinase PKC-θ determines its localization in the immunological synapse and functions in T cells via association with CD28.
Nat Immunol. 2011 Oct 2;12(11):1105-12. doi: 10.1038/ni.2120.
Zotero 插件